Details of the Drug

General Information of Drug (ID: DMITL03)

Drug Name

BMS-986231

Synonyms

N-Hydroxy-5-methylfuran-2-sulfonamide; Cimlanod; Cimlanod [USAN]; UNII-2US4FK1EPV; 2US4FK1EPV; SCHEMBL15878610; LIXKIXWSKOENAB-UHFFFAOYSA-N; ZINC145617689; 2-Furansulfonamide, N-hydroxy-5-methyl-; 1620330-72-4

Indication

Disease Entry	ICD 11	Status	REF
Acute decompensated heart failure	BD1Z	Phase 2	[1]
Acute heart failure	BD10-BD13	Phase 2	[2]
------------------------------------------------------------------------------------

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C5H7NO4S
Canonical SMILES: CC1=CC=C(O1)S(=O)(=O)NO
InChI: 1S/C5H7NO4S/c1-4-2-3-5(10-4)11(8,9)6-7/h2-3,6-7H,1H3
InChIKey: LIXKIXWSKOENAB-UHFFFAOYSA-N

Cross-matching ID

PubChem CID: 76685198
CAS Number: 1620330-72-4
TTD ID: D0AG8L

References

1	ClinicalTrials.gov (NCT02157506) A Dose Ranging Phase IIa Study of 6 Hour Intravenous Dosages of CXL-1427 in Patients Hospitalized With Heart Failure. U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)